STERIS plc

Symbol: STE

NYSE

225.99

USD

Market price today

  • 41.9191

    P/E Ratio

  • -0.7329

    PEG Ratio

  • 22.33B

    MRK Cap

  • 0.01%

    DIV Yield

STERIS plc (STE) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.43%

Operating Profit Margin

0.15%

Net Profit Margin

0.10%

Return on Assets

0.05%

Return on Equity

0.08%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Daniel A. Carestio
Full-time employees:17000
City:Dublin
Address:70 Sir John Rogerson’s Quay
IPO:1992-06-01
CIK:0001757898

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

General Outlook

When we look at how much money they make before expenses, they keep 0.432% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.149%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.098%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.048% return, is a testament to STERIS plc's adeptness in optimizing resource deployment. STERIS plc's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.085%. Furthermore, the proficiency of STERIS plc in capital utilization is underscored by a remarkable 0.080% return on capital employed.

Liquidity Ratios

Analyzing STE liquidity ratios reveals its financial health of the firm. The current ratio of 306.15% gauges short-term asset coverage for liabilities. The quick ratio (129.39%) assesses immediate liquidity, while the cash ratio (22.04%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio306.15%
Quick Ratio129.39%
Cash Ratio22.04%

Profitability Ratios

STE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 12.46% underscores its earnings before tax deductions. The effective tax rate stands at 21.17%, revealing its tax efficiency. The net income per EBT, 78.61%, and the EBT per EBIT, 83.57%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.91%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin12.46%
Effective Tax Rate21.17%
Net Income per EBT78.61%
EBT per EBIT83.57%
EBIT per Revenue14.91%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.06, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding129
Days of Inventory Outstanding80
Operating Cycle147.32
Days of Payables Outstanding30
Cash Conversion Cycle118
Receivables Turnover5.40
Payables Turnover12.27
Inventory Turnover4.58
Fixed Asset Turnover2.81
Asset Turnover0.49

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 9.45, and free cash flow per share, 6.01, depict cash generation on a per-share basis. The cash per share value, 2.09, showcases liquidity position. A payout ratio of 0.37 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.17, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share9.45
Free Cash Flow per Share6.01
Cash per Share2.09
Payout Ratio0.37
Operating Cash Flow Sales Ratio0.17
Free Cash Flow to Operating Cash Flow Ratio0.64
Cash Flow Coverage Ratio0.30
Capital Expenditure Coverage Ratio2.75
Dividend Paid and Capex Coverage Ratio1.74
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 28.18%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.49, we discern the balance between debt and equity financing. The long-term debt to capitalization, 33.07%, and total debt to capitalization, 33.07%, ratios shed light on its capital structure. An interest coverage of 7.49 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio28.18%
Debt Equity Ratio0.49
Long Term Debt to Capitalization33.07%
Total Debt to Capitalization33.07%
Interest Coverage7.49
Cash Flow to Debt Ratio0.30
Company Equity Multiplier1.75

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 52.02, provides a glimpse into top-line earnings distributed across each share. Net income per share, 3.83, reflects the portion of profit attributed to each share.

cards.indicatorcards.value
Revenue Per Share52.02
Net Income Per Share3.83
Capex Per Share-3.65

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 3.65%, indicates top-line expansion, while the gross profit growth, 2.71%, reveals profitability trends. EBIT growth, 211.77%, and operating income growth, 211.77%, offer insights into operational profitability progression. The net income growth, 253.40%, showcases bottom-line expansion, and the EPS growth, 257.94%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth3.65%
Gross Profit Growth2.71%
EBIT Growth211.77%
Operating Income Growth211.77%
Net Income Growth253.40%
EPS Growth257.94%
EPS Diluted Growth256.07%
Weighted Average Shares Growth-0.92%
Weighted Average Shares Diluted Growth-0.88%
Dividends per Share Growth10.32%
Operating Cash Flow Growth28.58%
Free Cash Flow Growth55.19%
10-Year Revenue Growth per Share89.08%
5-Year Revenue Growth per Share58.13%
3-Year Revenue Growth per Share42.62%
10-Year Operating CF Growth per Share177.13%
5-Year Operating CF Growth per Share54.45%
3-Year Operating CF Growth per Share21.72%
10-Year Net Income Growth per Share74.42%
5-Year Net Income Growth per Share6.51%
3-Year Net Income Growth per Share-17.91%
10-Year Dividend per Share Growth per Share147.43%
3-Year Dividend per Share Growth per Share29.25%
R&D Expense Growth2.07%
SGA Expenses Growth-3.58%

Other Metrics

Income quality, 2.56, assesses the reliability of reported earnings.

cards.indicatorcards.value
Income Quality2.56
Research and Development to Revenue2.02%
Capex to Operating Cash Flow-37.02%
Capex to Revenue-7.01%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.54, and the price to book ratio, 3.54, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.10, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 37.59, and price to operating cash flows, 23.91, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio3.54
Price to Book Ratio3.54
Price to Sales Ratio4.10
Price Cash Flow Ratio23.91
Price Earnings to Growth Ratio-0.73
Enterprise Value Multiple20.35
Price Fair Value3.54
Price to Operating Cash Flow Ratio23.91
Price to Free Cash Flows Ratio37.59
Earnings Yield1.73%
Free Cash Flow Yield2.81%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of STERIS plc (STE) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 41.919 in 2024.

What is the ticker symbol of STERIS plc stock?

The ticker symbol of STERIS plc stock is STE.

What is company IPO date?

IPO date of STERIS plc is 1992-06-01.

What is company current share price?

Current share price is 225.990 USD.

What is stock market cap today?

The market cap of stock today is 22330975860.000.

What is PEG ratio in 2024?

The current -0.733 is -0.733 in 2024.

What is the number of employees in 2024?

In 2024 the company has 17000.